Long-Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study

Brian Schwartz,Colin Pierce,C. Madelaire,Morten Schou,Søren Lund Kristensen,Gunnar Gislason,Lars Køber,Christian Torp-Pedersen,Charlotte Andersson

Long-Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study

2021

Brian Schwartz
Colin Pierce
C. Madelaire
Morten Schou
Søren Lund Kristensen
Gunnar Gislason
Lars Køber
Christian Torp-Pedersen
Charlotte Andersson

Background Carvedilol may have favorable glycemic properties compared with metoprolol, but it is unknown if carvedilol has mortality benefit over metoprolol in patients with type 2 diabetes (T2D) a...

Keywords:

long term mortality
Cohort study
Danish
Glycemic
Type 2 diabetes
Metoprolol
Internal medicine
Heart failure
Carvedilol
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations